Research Homepage

See all  |  View the Research news feed

News & stories

A common diabetes medication may slow memory decline in Alzheimer's disease
Researchers at Sunnybrook Research Institute and the University of Toronto found that the rate of memory decline was slower in people with Alzheimer’s disease taking a specific class of anti-diabetic drug, known as a dipeptidyl peptidase-4 (DPP4) inhibitor.
Two Sunnybrook-led studies awarded funding through the Ontario COVID-19 Rapid Research Fund
The $20-million fund will support researchers working to find ways to prevent, detect and treat COVID-19.
Sunnybrook researchers have developed a new way to detect hearing loss in blood
Scientists demonstrated a way to detect hearing disorders using a simple blood test


There are no upcoming events.
View events calendar

Jargon decoder

A glossary for research terms used on the website
A · B · C · D · E · F · G · H · I · J · K · L · M · N · O · P · Q · R · S · T · U · V · W · X · Y · Z

For researchers & administrators

Scientist profiles
We have more than 300 scientists
Clinical research services
Help with trials and research ethics
Core facilities
For internal and external use
Research executive committee

SRI scientists in the news

How is poor sleep affecting the health of Ontarians?
Preliminary data show good quality slumber eludes many
Sleep disruptions related to changes in immune cells in brain and worse cognition: study
New research may help explain link between poor slumber and dementia